<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105808">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01798862</url>
  </required_header>
  <id_info>
    <org_study_id>121212</org_study_id>
    <nct_id>NCT01798862</nct_id>
  </id_info>
  <brief_title>Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles</brief_title>
  <official_title>The Effect of Endometrial Injury on IVF Outcome Parameters in Patients With Failed IVF Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <authority>Greece: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The iatrogenic induction of local endometrial injury caused through hysteroscopy or pipelle
      sampling in the preceding non- transfer cycle improves the IVF outcome parameters in
      patients with previous IVF failures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endometrial injury was preformed either through hysteroscope during office hysteroscopy
      through the non touch technique or through pipelle biopsy in the early follicular phase
      (days 5 to 9) in the preceding cycle of the IVF treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Live Birth Rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ectopic pregnancy rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy complications (preterm birth, placental abnormalities, bleeding throughout pregnancy, pregnancy related hypertensive disorders, IUGR and SGA)</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Positive pregnancy test</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infertility/ Failed IVF Cycles</condition>
  <arm_group>
    <arm_group_label>Endometrial injury by hysteroscopy or pipelle sapling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endometrial Sampling by pipelle or hysteroscopy performed once between 6th to 10th day in the cycle prior to the fresh IVF/ ICSI cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COH for IVF without hysteroscopy or pipelle sampling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure: COH for IVF Both GnRH agonists (long, starting at day 2 or 21) with triptorelin acetate 0.1 mg (Gonapeptyl daily) and antagonists with ganirelix 0.25mg (Orgalutran) or cetrorelix 0.25mg (Cetrotide) protocols will be used; for ovarian stimulation both recombinant FSH ( Puregon) and human menopausal gonadotrophin ( Menopur) will be used. Ovarian response will be monitored by ultrasonography, oocyte retrieval will be performed 36-38 hours after the Hcg triggering and for luteal phase support 600 mg progesterone tablets ( Utrogestan) will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endometrial injury by hysteroscopy or pipelle sampling</intervention_name>
    <arm_group_label>Endometrial injury by hysteroscopy or pipelle sapling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Proceed to COH directly</intervention_name>
    <arm_group_label>COH for IVF without hysteroscopy or pipelle sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Personal history of  2 or more failed IVF/ICSI cycles

          -  Age&lt; 42 years

          -  Good response with good quality embryos in previous attempts

        Exclusion Criteria:

          -  Personal history of endometrial tuberculosis/ antituberculous treatment

          -  Sonographically detected hydrosalpinges

          -  Intramural fibroids distorting the endometrial cavity, submucous myomas or Asherman's
             syndrome

          -  Thrombophilia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Kreatsa, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National and Kapodistrian University of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charalampos Siristatidis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Kapodistrian University of Athens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Kreatsa, MD, PhD</last_name>
    <phone>694-799-6525</phone>
    <phone_ext>0030</phone_ext>
    <email>mar_kreatsa@yahoo.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charalampos Siristatidis, Assistant Professor</last_name>
    <phone>693-229-4994</phone>
    <phone_ext>0030</phone_ext>
    <email>harrysiri@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assisted Reproduction Unit 3rd Department of Obstetrics &amp; Gynecology, Attikon University Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>12642</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Kreatsa, MD, PhD</last_name>
      <phone>694-799-6525</phone>
      <phone_ext>0030</phone_ext>
      <email>mar_kreatsa@yahoo.gr</email>
    </contact>
    <investigator>
      <last_name>George Salamalekis, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charalampos Chrelias, Assistant Prof OB/GYN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tereza Vrantza, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paraskevi Vogiatzi, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitrios Kassanos, Prof OB/GYN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assisted Reproduction Unit</name>
      <address>
        <city>Alexandroupolis</city>
        <state>Thrace</state>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georgios Galazios, Professor</last_name>
      <email>ggalaz@med.duth.gr</email>
    </contact>
    <investigator>
      <last_name>Georgios Galazios, Professor OG/GYN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikoletta Koutlaki, Ass Prof OB/GYN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Baum M, Yerushalmi GM, Maman E, Kedem A, Machtinger R, Hourvitz A, Dor J. Does local injury to the endometrium before IVF cycle really affect treatment outcome? Results of a randomized placebo controlled trial. Gynecol Endocrinol. 2012 Dec;28(12):933-6. doi: 10.3109/09513590.2011.650750. Epub 2012 Sep 3.</citation>
    <PMID>22943664</PMID>
  </reference>
  <results_reference>
    <citation>Karimzadeh MA, Ayazi Rozbahani M, Tabibnejad N. Endometrial local injury improves the pregnancy rate among recurrent implantation failure patients undergoing in vitro fertilisation/intra cytoplasmic sperm injection: a randomised clinical trial. Aust N Z J Obstet Gynaecol. 2009 Dec;49(6):677-80. doi: 10.1111/j.1479-828X.2009.01076.x.</citation>
    <PMID>20070722</PMID>
  </results_reference>
  <results_reference>
    <citation>Narvekar SA, Gupta N, Shetty N, Kottur A, Srinivas M, Rao KA. Does local endometrial injury in the nontransfer cycle improve the IVF-ET outcome in the subsequent cycle in patients with previous unsuccessful IVF? A randomized controlled pilot study. J Hum Reprod Sci. 2010 Jan;3(1):15-9. doi: 10.4103/0974-1208.63116.</citation>
    <PMID>20607003</PMID>
  </results_reference>
  <results_reference>
    <citation>El-Toukhy T, Sunkara S, Khalaf Y. Local endometrial injury and IVF outcome: a systematic review and meta-analysis. Reprod Biomed Online. 2012 Oct;25(4):345-54. doi: 10.1016/j.rbmo.2012.06.012. Epub 2012 Jun 26. Review.</citation>
    <PMID>22885017</PMID>
  </results_reference>
  <results_reference>
    <citation>Potdar N, Gelbaya T, Nardo LG. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod Biomed Online. 2012 Dec;25(6):561-71. doi: 10.1016/j.rbmo.2012.08.005. Epub 2012 Sep 12.</citation>
    <PMID>23063812</PMID>
  </results_reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 29, 2013</lastchanged_date>
  <firstreceived_date>February 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Siristatidis Charalampos, MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor in Obstetrics and Gynecology / Assisted Reproduction</investigator_title>
  </responsible_party>
  <keyword>Failed IVF cycles</keyword>
  <keyword>IVF outcome parameters</keyword>
  <keyword>endometrial injury</keyword>
  <keyword>hysteroscopy</keyword>
  <keyword>pipelle sampling</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
